Open main menu
Search Ctrl + K
Free Trial
Loading...
X4 Pharmaceuticals, Inc
Watch
Biological Products, (no Diagnostic Substances)
NASDAQ.XFOR
61 North Beacon Street, 4th Floor, Boston, MA, 02134
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Ownership
4
Ragan Paula
19 Nov 24
144
Ragan Paula
15 Nov 24
SC 13G/A
12 Nov 24
SC 13G
08 Nov 24
SC 13G/A
04 Nov 24
SC 13G
22 Oct 24
4
Ragan Paula
16 Oct 24
Prospectuses and Registrations
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
04 Oct 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
25 Jan 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
14 Aug 23
424B3
Prospectus Filed Pursuant To Rule 424(b)(3).
21 Jun 23
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
20 Jan 23
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
09 Dec 22
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
07 Dec 22
Proxies
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
29 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
29 Apr 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
27 Apr 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
25 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
25 Apr 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
11 Aug 22
PRE 14A
Preliminary Proxy Statement Not Yet Definitive.
01 Aug 22
News
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
13 Nov 24
8-K
Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
13 Nov 24
8-K
Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing
16 Aug 24
8-K
Regulation Fd Disclosure
09 Aug 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 Aug 24
8-K
Regulation Fd Disclosure
19 Jul 24
8-K
Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing
14 Nov 23
Other
ARS
Scanned Paper Annual Report Submission.
29 Apr 24
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
24 Aug 23
CORRESP
Correspondence With The Sec.
22 Aug 23
UPLOAD
Letter From The Sec.
21 Aug 23
S-3
Registration Statement Under The Securities Act.
14 Aug 23
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
20 Jun 23
UPLOAD
Letter From The Sec.
16 Jun 23
Financials
10-Q
Quarterly Filing
13 Nov 24
10-Q
Quarterly Filing
08 Aug 24
10-Q
Quarterly Filing
07 May 24
10-K
Fiscal Year 2023
21 Mar 24
10-Q
Quarterly Filing
09 Nov 23
10-Q
Quarterly Filing
10 Aug 23
10-Q
Quarterly Filing
04 May 23